Tyler Dylan-Hyde, Chief Legal Officer at CRISPR Therapeutics AG (CRSP), sold 18,044 shares at $17.37 ($317K) on 2017-04-20, disclosed to the SEC on 2017-04-21.
Open-market sale of $317k CRSP by Chief Legal Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.49 | 4,930 | $86K | 27.2% |
| 2 | $17.49 | 4,930 | $86K | 27.2% |
| 3 | $18.58 | 2,310 | $43K | 13.5% |
| 4 | $17.37 | 2,937 | $51K | 16.1% |
| 5 | $17.37 | 2,937 | $51K | 16.1% |
| Total | $17.59 avg | 18,044 |
| $317K |
| 100% |
| Filing → |
| CRSP | SELL | 2018-01-02 | $840K | — | Filing → |
| CRSP | SELL | 2017-12-27 | $308K | — | Filing → |
| CRSP | SELL | 2017-12-19 | $284K | — | Filing → |